DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5,808 Cr | ₹-4,028 Cr | ₹-4,137 Cr | ₹-2,639 Cr | ₹-2,266 Cr |
What is the latest Cash Flow from Investing Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5,808 Cr |
| Mar2024 | ₹-4,028 Cr |
| Mar2023 | ₹-4,137 Cr |
| Mar2022 | ₹-2,639 Cr |
| Mar2021 | ₹-2,266 Cr |
How is Cash Flow from Investing Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5,808 Cr | Negative | |
| Mar2024 | ₹-4,028 Cr | Negative | |
| Mar2023 | ₹-4,137 Cr | Negative | |
| Mar2022 | ₹-2,639 Cr | Negative | |
| Mar2021 | ₹-2,266 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹107,759.4 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
| MANKIND PHARMA | ₹91,013.2 Cr | 2.3% | 6.7% | -3.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.2% |
9.2% |
14.9% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses